Actively Recruiting
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
Led by Technische Universität Dresden · Updated on 2025-01-09
3000
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
Sponsors
T
Technische Universität Dresden
Lead Sponsor
U
University Hospital Carl Gustav Carus
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prospective, single-centre study with the central question of how the metabolome from blood samples, different body fluids and tissues between patients patients with malignant melanoma in different tumour tumour stages and healthy patients and whether this is suitable for early detection of initial diagnosis, recurrence or stage shift at an early stage. The biosamples are collected in the BioBank Dresden and used for the NMR and LC-MS analyses described here. It is planned to use the biosamples for further analyses.
CONDITIONS
Official Title
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Current or past history of melanoma
- Ongoing therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital
You will not qualify if you...
- Refusal to participate in the study
- Lack of capacity to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Carl Gustav Carus
Dresden, Saxony, Germany, 01307
Actively Recruiting
Research Team
F
Frank Friedrich Gellrich, Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here